To assess patients' perspectives on the severity and time course of swallowing deficit pre-and post-(chemo)radiotherapy for head and neck cancer. To evaluate the relative priority patients attribute to swallowing compared with other quality of life domains. METHOD: Subjects: 167 patients with a primary cancer, mostly of larynx or pharynx subsites. Setting: Head and neck cancer UK multidisciplinary clinic. Patients completed the MD Anderson Dysphagia Index (MDADI) and the University of Washington Quality of Life Questionnaire. (UWQOL) pretreatment and at three, six, and 12 months. Variables assessed were pretreatment swallowing, age, gender, tumor site/stage. Statistical Methods: Mann Whitney, ANOVA and logistic regression.
B6, nϭ9 D2), or sham surgery (S) (nϭ5 B6, nϭ9 D2) were performed. Mice underwent post-surgical lick testing. Microscopic analysis of tongue papillae and postmortem dissections were performed. RESULTS: In both strains, HX and LX mice licked more than sham mice. Volume per lick was significantly decreased in the surgical groups relative to shams. D2 HX and LX mice consumed abnormally small volumes per lick. Motor or sensory nerve transection had no effect on lick rate. In most LX mice in both strains, taste papillae were missing or reduced compared to HX or sham mice. In neither strain did papillae in HX mice differ from sham mice. Mice undergoing sensory and motor nerve cuts experienced a nearly equal amount of weight loss postoperatively. CONCLUSION: Mice with either a sensory or motor nerve injury have a loss of lick accuracy with ingestion. However, neither oromotor movements nor lick rate are affected by sensory or motor nerve cuts. These appear to be under the control of central pattern generators. Significant regeneration of taste buds by postoperative day 14 (in B6 mice) and 26 (in D2 mice) was noted. LX results in greater loss of papillae than HX or S.
Effect of Treatment on Systemic Levels of Cytokines in HNSCC
Nicholas Stafford, MB, ChB, FRCS (presenter); John Greenman, PhD OBJECTIVE: 1) Determine the levels of Th1 and Th2 cytokines in the serum of HNSCC patients both prior to and after treatment. 2) Identify the effect of HNSCC sub-site on cytokine detectability. METHOD: IL2, IL4, IL5, IL6, IL8, IL10, IL13, GMCSF, IFN gamma, and TNF alpha were measured in the serum of 44 newly presenting HNSCC patients, prior to and following their treatment, using a Quantibody array based multiplex sandwich ELISA (Raybiotech). The results from four patients were excluded due to low/absent levels of all cytokines. Results were analyzed on 5 oral, 8 oropharyngeal, 17 laryngeal and 10 other patients. RESULTS: A significant decrease in the levels of the Th2 cytokines IL5, IL6 and IL10 was observed between the pretreatment and post-treatment serum samples (pϭ0.035, 0.001 and 0.004 respectively, Wilcoxon signed ranks test). The Th1 cytokine IL2 also decreased (pϭ0.02) as did GM-CSF which is secreted by both Th1 and Th2 cells (pϭ0.04). No difference in the detectability of any of the cytokines was observed between pre-and post-treatment samples (Fishers exact test), however sub-site specific differences were observed pre-treatment, i.e., laryngeal patients showed a significantly higher frequency of IL4, IL13 and IFN gamma detectability; a difference lost following treatment ( 2 test). CONCLUSION: These results indicate that both treatment and sub-site of the tumor affect systemic cytokine levels;
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